Children's Therapy for Emotional and Behavioral Issues
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. However, since medication tracking is part of the study, it seems likely that participants can continue their current medications.
What data supports the effectiveness of the treatment Modular Approach to Therapy for Children with Anxiety, Depression, Trauma or Conduct Problems (MATCH-ADTC)?
Research shows that MATCH-ADTC outperformed usual care and standard treatments in clinical trials in the USA, improving outcomes for children with anxiety, depression, trauma, and conduct problems. It is designed to be flexible and address multiple issues at once, making it more effective in real-world settings where children often have more than one problem.12345
Is the Modular Approach to Therapy for Children (MATCH-ADTC) safe for children?
How is the MATCH-ADTC treatment different from other treatments for children's emotional and behavioral issues?
MATCH-ADTC is unique because it uses a flexible, modular approach to address multiple issues like anxiety, depression, trauma, and conduct problems in children, allowing it to adapt to changing needs and comorbidities (multiple conditions at once) more effectively than standard treatments that focus on one issue at a time.12378
What is the purpose of this trial?
The goal of this clinical trial is to learn about how psychotherapy works for children and adolescents aged 8 - 15 with anxiety, depression, trauma, or disruptive behaviour. The main question it aims to answer is:• Is the biobehavioural regulation of negative emotion a transdiagnostic mechanism of treatment response in psychotherapy for children with anxiety, depression, trauma and/or disruptive behaviour?Children and their parents will be randomly assigned to an evidence-based, transdiagnostic treatment (the Modular Approach to Therapy for Children with Anxiety, Depression, Trauma, and Conduct Problems; MATCH-ADTC) or a waitlist control condition. Participants in both groups will complete a baseline assessment, weekly measures consisting of brief symptom scales and medication tracking, and quarterly assessments every 3 months. Following the intervention/waitlist period, our team will conduct post-test assessments. All assessments, except for the weekly surveys, will consist of symptom scales, clinical interviews, experimental tasks and physiological measures.
Research Team
Kristel Thomassin, PhD
Principal Investigator
University of Guelph
Eligibility Criteria
This trial is for children aged 8-15 with anxiety, depression, trauma or disruptive behavior who speak English. Their parents must also speak English and be over 18. The study seeks to understand how therapy can help manage emotions in these children.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete a baseline assessment including symptom scales, clinical interviews, experimental tasks, and physiological measures
Treatment/Waitlist
Participants receive the MATCH-ADTC treatment or are placed on a waitlist. Weekly measures include brief symptom scales and medication tracking
Quarterly Assessments
Participants undergo quarterly assessments every 3 months, including symptom scales, clinical interviews, experimental tasks, and physiological measures
Post-test Assessment
Post-test assessments are conducted after the intervention/waitlist period, including symptom scales, clinical interviews, experimental tasks, and physiological measures
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Modular Approach to Therapy for Children with Anxiety, Depression, Trauma or Conduct Problems
Modular Approach to Therapy for Children with Anxiety, Depression, Trauma or Conduct Problems is already approved in United States for the following indications:
- Anxiety
- Depression
- Trauma
- Conduct Problems
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Guelph
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator
Centre for Addiction and Mental Health
Collaborator